Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Albuterol Payments Could Be Cut 85% By Using FSS Prices - HHS IG

Executive Summary

Medicare could save $209 mil. on its total 1999 albuterol payments of $246 mil. if the program used federal supply schedule prices, an HHS Inspector General report finds.

You may also be interested in...



Medicare Should Consider FSS-Like Fee Schedule For Covered Drugs - IG

Creating a fee schedule for Medicare-covered drugs that is similar to the Federal Supply Schedule is one option to reduce excessive prescription drug reimbursement amounts, a HHS Office of Inspector General report recommends.

Medicare Should Consider FSS-Like Fee Schedule For Covered Drugs - IG

Creating a fee schedule for Medicare-covered drugs that is similar to the Federal Supply Schedule is one option to reduce excessive prescription drug reimbursement amounts, a HHS Office of Inspector General report recommends.

House Medicare Rx Bill Calls For GAO Study Of Part B Payments Prior To Cuts

The General Accounting Office would conduct a study of Medicare payment levels for currently covered drugs and biologics under an amendment to Medicare prescription drug legislation that was approved by the House Ways & Means Committee June 21.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel